Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease
MULTICAMPO
1 other identifier
interventional
48
1 country
1
Brief Summary
Homonymous visual field defects (HVFDs) after acquired brain injuries affect daily life by impairing reading, navigation, and social activities, often impacting anxiety and depression. Spontaneous recovery is rare. Rehabilitation approaches include restorative treatments, which aim to expand the visual field through the stimulation of the so-called transition zone, and compensatory strategies, such as audio-visual training (AVT), which combines eye movement exercises with synchronized visual and auditory cues to train oculomotor scanning and overcome the visual field loss. Combining AVT with non-invasive brain stimulation, such as transcranial direct current stimulation (tDCS), may enhance recovery by promoting brain plasticity. Early evidence suggests that tDCS applied to the lesioned visual cortex during AVT can speed and stabilize improvements, potentially also restoring parts of the visual field. However, most studies on AVT have focused on chronic patients, whereas several clinical trials and international guidelines indicate that early treatment of HVFDs in the subacute phase can optimally exploit the window of maximal neural plasticity and prevent secondary degenerative processes, thereby maximizing visual recovery. In the present randomized clinical trial, we assess the efficacy of a multisensory audio-visual training (AVT) combined with tDCS in patients with subacute HVFDs after stroke (\<3 months post-lesion). Participants are randomly assigned to two groups: AVT combined with real anodal tDCS applied to the lesioned occipital cortex (Group 1), or AVT combined with sham tDCS (Group 2). The AVT requires participants to orient their gaze toward spatio-temporally congruent, cross-modal audio-visual stimuli (starting from a central fixation) and press a button as quickly as possible upon detecting the visual target. All stimuli are presented on 2mx2m panel embedded with 40 LEDs and loudspeakers (Diana, Casati, Melzi, Marzoli, et al., 2024). The training will be administered for 90 minutes daily over 10 consecutive days. All participants underwent a neuro-ophthalmological evaluation and neuropsychological assessment of visuospatial functions before the beginning of the training (t0), at the end of the training (t1), at 2 months (t2) and after 1 year (t3).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2029
January 22, 2026
January 1, 2026
2.1 years
January 14, 2026
January 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in Humphrey Visual Field perimetry
Mean Deviation (MD) values of both eyes will be averaged and used for the analyses. Negative values will reflect a deviation from the expected performance in the participant's age group, hence a visual field defect.
At baseline (at the beginning of the treatment), at the end of the treatment, at 2- and 12-month follow-ups
Secondary Outcomes (6)
Change from baseline in Accuracy and reaction time on the EF Task
At baseline (at the beginning of the treatment), at the end of the treatment, at 2- and 12-month follow-ups
Change from baseline in Accuracy and Reaction times on the Triangle Task
At baseline (at the beginning of the treatment), at the end of the treatment, at 2- and 12-month follow-ups
Change from baseline in Accuracy and RTs on the Visual Detection Task
At baseline (at the beginning of the treatment), at the end of the treatment, at 2- and 12-month follow-ups
Change in retinal layers thickness assessed with Spectral Domain Optical Coherence Tomography
At baseline (at the beginning of the treatment), at 2- and 12-month follow-ups
Change in Visual Evoked Potential amplitude
At baseline (at the beginning of the treatment), at the end of the treatment and at 12-month follow-ups
- +1 more secondary outcomes
Study Arms (2)
Anodal Occipital tDCS + audio-visual training
EXPERIMENTALAnodal tDCS on ipsilesional occipital cortex. Anode electrode placed on O1/O2 (10-20 EEG system) and reference electrode placed on the contralateral forehead. Stimulation delivered at 2mA during the first 30 minutes of the audio-visual training.
Sham tDCS + audio-visual training
SHAM COMPARATORSame montage as for Experimental group. Stimulator is turned off after 30s of the audio-visual training.
Interventions
Anodal or sham tDCS (see "Arms") is applied during the execution of an audio-visual training.
90 min/day x 10 days. Participants are seated in front of a 2 m × 2 m training board, at a distance of 1.2 m, in a dimly lit room. The board features 48 red light-emitting diodes (LED, diameter 1 cm, luminance 90 cd m2), distributed in six horizontal rows (eight lights per row). Forty-eight piezoelectric loudspeakers (0.4 W, 8Ω) are located above each light, producing a white-noise (80 dB, duration 100 ms). Spatio-temporally congruent, cross-modal, audio-visual stimuli are presented at one out of 48 possible positions on the board. Participants are instructed to look at the fixation point - at the center of the apparatus - and to move their eyes to detect the presence of the visual stimulus (duration=100 ms) by pressing right button of a wireless mouse.
Eligibility Criteria
You may qualify if:
- \- Presence of subacute acquired brain injury (\< 3 months) with HVFD according to Neurophthalmological evaluation
You may not qualify if:
- Presence of hemispatial neglect (indexed by pathological asymmetries on paper-and-pencil tests)
- Disorders of conjugated eye movements
- Other neurological disorders (e.g., dementia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Auxologico Italiano IRCCS
Milan, Lombardy, 20122, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2026
First Posted
January 22, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
February 28, 2028
Study Completion (Estimated)
January 31, 2029
Last Updated
January 22, 2026
Record last verified: 2026-01